CD 130 (Ranitidine hydrochloride 300 mg)

Pill imprint CD 130 has been identified as Ranitidine hydrochloride 300 mg.

Ranitidine is used in the treatment of gerd; erosive esophagitis; stomach ulcer; gastric ulcer maintenance treatment; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for CD 130 (Ranitidine hydrochloride 300 mg)

Ranitidine hydrochloride 300 mg CD 130
Ranitidine hydrochloride
Imprint:
CD
130
Strength:
300 mg
Color:
Brown
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC):
55111-0130
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
ferrosoferric oxide
ferric oxide red
ferric oxide yellow
titanium dioxide
gelatin
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
49884-0648 Par Pharmaceutical

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web4)